// company-profile
Monte Rosa Therapeutics, Inc. Insider Trading
GLUEEvery SEC Form 4 insider trading filing for Monte Rosa Therapeutics, Inc. (GLUE) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
curl "https://api.form4api.com/v1/transactions?ticker=GLUE" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
Recent insider activity is bearish. Over the last 30 days, insiders net sold $220K across 1 transaction.
// 90-day insight
Over the last 90 days, Monte Rosa Therapeutics, Inc. insiders bought $42K (9 transactions) and sold $451K (2 transactions).
- Most active insider: Townson Sharon with 13 transactions totaling $487K.
- Largest single sale: $643K by Janku Filip on Jun 24, 2026.
- 88% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Monte Rosa Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | Warmuth Markus | GLUE | Sale | 9,500 | $23.18 | $220K |
| Jul 15, 2026 | Champoux Jennifer | GLUE | Option Exercise10b5 | 4,351 | $0.00 | $0K |
| Jul 15, 2026 | Champoux Jennifer | GLUE | Option Exercise10b5 | 4,351 | $3.98 | $17K |
| Jul 15, 2026 | Champoux Jennifer | GLUE | Sale10b5 | 4,351 | $23.38 | $102K |
| Jul 6, 2026 | Townson Sharon | GLUE | Option Exercise10b5 | 6,000 | $6.14 | $37K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →